Skip to main content
Dana Pizzuti, MD, Internal Medicine, Palo Alto, CA

DanaPizzutiMD

Internal Medicine Palo Alto, CA

Infectious Disease

Senior Vice President, Development Operations and Chief Medical Officer

Dr. Pizzuti is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Pizzuti's full profile

Already have an account?

Education & Training

  • New York University School of Medicine
    New York University School of MedicineClass of 1981

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2007 - 2025
  • NY State Medical License
    NY State Medical License 1982 - 2025
  • NJ State Medical License
    NJ State Medical License 1989 - 2015
  • IL State Medical License
    IL State Medical License 1992 - 2008
  • American Board of Internal Medicine Internal Medicine

Press Mentions

  • Human Growth Hormone Deficiency (GHD) Drugs Market : Facts, Figures and Analytical Insights 2020-2023
    Human Growth Hormone Deficiency (GHD) Drugs Market : Facts, Figures and Analytical Insights 2020-2023October 27th, 2020
  • Ascendis Pharma A/S Receives Orphan Designation for TransCon™ PTH for Treatment of Hypoparathyroidism in Europe
    Ascendis Pharma A/S Receives Orphan Designation for TransCon™ PTH for Treatment of Hypoparathyroidism in EuropeOctober 23rd, 2020
  • Ascendis Pharma A/S Submits Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for TransCon™ hGH for Treatment of Pediatric Growth Hormone Deficiency
    Ascendis Pharma A/S Submits Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for TransCon™ hGH for Treatment of Pediatric Growth Hormone DeficiencySeptember 8th, 2020
  • Join now to see all

Professional Memberships